The Link between Parkinson’s disease and diabetes

The Link between Parkinson’s disease and diabetes

A recent study demonstrated an association between Parkinson’s disease and diabetes. Dr. Gilbert explains why the connection between these two conditions is important and how an understanding of the relationship between Parkinson’s disease and diabetes may open up new treatment avenues for Parkinson’s disease.

Read More

Anti-cholinergic Drugs – A Risk Factor For Dementia?

Anti-cholinergic Drugs – A Risk Factor For Dementia?

You may have read that certain medication prescribed for Parkinson’s disease can cause dementia. Dr. Gilbert will weigh in on the science behind this topic, including how these drugs work, and if there’s any casual relationship between them and an increased risk of dementia.

Read More

Spring Arrives at APDA: the Scientific Advisory Board Meeting

Spring Arrives at APDA: the Scientific Advisory Board Meeting

The spring brings with it hope, renewal, and promise, the perfect backdrop for American Parkinson Disease Association’s (APDA) yearly Scientific Advisory Board (SAB) meeting at which most exciting and promising research ideas for APDA grant funding is reviewed and recommended to the APDA Board of Directors. This year, the meeting took place on May 17, 2018.

Pictured: APDA SAB Members work diligently to determine which grants will be recommended for funding.

Read More

Understanding Stem Cell Therapy in Parkinson’s Disease Treatment

On April 29, 2018, the Washington Post published an article

examining commercial stem cell clinics in the United States that market non-FDA approved treatments directly to the public for a variety of health issues, including arthritis, macular degeneration and of particular note to us, Parkinson’s disease (PD).

Pictured: Dopamine neurons derived from iPSCs from the lab of Xiaobo Mao, Phd

Read More

Lewy Bodies, Dementia, and Parkinson’s – What Does it all Mean?

Here are two common scenarios that may sound familiar:

Scenario 1
A patient develops a series of neurologic symptoms, is evaluated by a neurologist and is told that she has Parkinson’s disease (PD). She then visits another neurologist for a second opinion and is told she has Lewy Body Dementia (LBD).

Scenario 2
A patient has his first visit with his neurologist and is told that he has PD, at a subsequent visit the diagnosis is changed to Parkinson’s disease dementia (PDD), and at a follow up visit the diagnosis is changed yet again to Dementia with Lewy Bodies (DLB).

Both of these situations understandably cause great uncertainty and frustration.

Read More

Introducing A Closer Look

In today’s hyper-connected world, you can find an almost infinite amount of information about Parkinson’s disease (PD) in every corner of the internet and on every social media outlet. It can be hard to know what to read, what to believe, and most importantly, what changes you should (or shouldn’t) implement in your life in response to the information that is out there.

Read More